Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional Databases.
Satoru MitsuboshiHirofumi HamanoYurika KunikiTakahiro NiimuraMasayuki ChumaSoichiro UshioTsung-Jen LinJun MatsumotoTatsuaki TakedaMakoto KajizonoYoshito ZamamiKeisuke IshizawaPublished in: The Annals of pharmacotherapy (2023)
The data in 2 separate databases consistently suggest that PPIs may increase the risk of rhabdomyolysis. The evidence for this association should be assessed in further drug safety studies.